Polymorphism of the cytochrome P450 (CYP) 2C9 gene in Japanese epileptic patients:: genetic analysis of the CYP2C9 locus

被引：119
|
作者：
Imai, J
Ieiri, I
Mamiya, K
Miyahara, S
Furuumi, H
Nanba, E
Yamane, M
Fukumaki, Y
Ninomiya, H
Tashiro, N
Otsubo, K
Higuchi, S
机构：
[1] Tottori Univ, Fac Med, Dept Hosp Pharm, Yonago, Tottori 6838504, Japan
[2] Tottori Univ, Ctr Gene Res, Yonago, Tottori 6838504, Japan
[3] Kyushu Univ, Inst Genet Informat, Higashi Ku, Fukuoka, Japan
[4] Kyushu Univ, Fac Med, Div Pharmaceut Sci, Higashi Ku, Fukuoka, Japan
[5] Kyushu Univ, Fac Med, Dept Neuropsychiat, Higashi Ku, Fukuoka, Japan
来源：
PHARMACOGENETICS | 2000年 / 10卷 / 01期
关键词：
CYP2C9; genetic analysis; polymorphism; new mutations; Japanese;
D O I：
10.1097/00008571-200002000-00011
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
[No abstract available]
引用
收藏
页码：85 / 89
页数：5
相关论文
共 50 条
  • [41] Structural Basis of Single-Nucleotide Polymorphisms in Cytochrome P450 2C9
    Maekawa, Keiko
    Adachi, Motoyasu
    Matsuzawa, Yumiko
    Zhang, Qinghai
    Kuroki, Ryota
    Saito, Yoshiro
    Shah, Manish B.
    BIOCHEMISTRY, 2017, 56 (41) : 5476 - 5480
  • [42] A systematic genetic polymorphism analysis of the CYP2C9 gene in four different geographical Han populations in mainland China
    Xiong, Yuyu
    Wang, Ming
    Fang, Ke
    Xing, Qinghe
    Feng, Guoyin
    Shen, Lu
    He, Lin
    Qin, Shengying
    GENOMICS, 2011, 97 (05) : 277 - 281
  • [43] CYP2C9 polymorphisms in human tumors
    Knüpfer, H
    Stanitz, D
    Preiss, R
    ANTICANCER RESEARCH, 2006, 26 (1A) : 299 - 305
  • [44] Distribution of CYP2C9*13 allele in the Chinese Han and the long-range haplotype containing CYP2C9*13 and CYP2C19*2
    Si, Dayong
    Wang, Juan
    Zhang, Yifan
    Zhong, Dafang
    Zhou, Hui
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2012, 33 (06) : 342 - 345
  • [45] Association between the CYP2C9 polymorphism and the drug metabolism phenotype
    Topic, E
    Stefanovic, M
    Samardzija, M
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2004, 42 (01) : 72 - 78
  • [46] A network meta-analysis of CYP2C9, CYP2C9 with VKORC1 and CYP2C9 with VKORC1 and CYP4F2 genotype-based warfarin dosing strategies compared to traditional
    Sridharan, Kannan
    Sivaramakrishnan, Gowri
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021, 46 (03) : 640 - 648
  • [47] Cytochrome P4502C9 (CYP2C9) allele frequencies in canadian native indian and inuit populations
    Gaedigk, A
    Casley, WL
    Tyndale, RF
    Sellers, EM
    Jurima-Romet, M
    Leeder, JS
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2001, 79 (10) : 841 - 847
  • [48] Frequency of CYP2C9 variant alleles, including CYP2C9*13 in a Korean population and effect on glimepiride pharmacokinetics
    Lee, H. W.
    Lim, M. -S.
    Lee, J.
    Jegal, M. -Y.
    Kim, D. -W.
    Lee, W. -K.
    Jang, I. -J.
    Shin, J. -G.
    Yoon, Y. -R.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2012, 37 (01) : 105 - 111
  • [49] Human CYP2C-mediated stereoselective phenytoin hydroxylation in Japanese: Difference in chiral preference of CYP2C9 and CYP2C19
    Yasumori, T
    Chen, LS
    Li, QH
    Ueda, M
    Tsuzuki, T
    Goldstein, JA
    Kato, R
    Yamazoe, Y
    BIOCHEMICAL PHARMACOLOGY, 1999, 57 (11) : 1297 - 1303
  • [50] Genetic analysis of the cytochrome P450 CYP2D6 polymorphism in patients with systemic lupus erythematosus
    Sabbagh, N
    Marez, D
    Queyrel, V
    Lo Guidice, JM
    Spire, C
    Vanhille, P
    Jorgensen, C
    Hachulla, E
    Broly, F
    PHARMACOGENETICS, 1998, 8 (03): : 191 - 194
12345